NOS2 and hepatocellular carcinoma: Furthermore, we highlighted the inhibitory effect of AEGT on HCV-induced inflammatory mediators including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), inducible nitric oxide synthase (iNOS) and COX-2 to assess its potential supplement use against HCV-related HCC.